Ghana

This global project, also under the MOMENTUM suite of awards (see above), supports countries—including Ghana—to improve the quality of care provided by the private health care sector and increase opportunities for a total market approach to quality services, products and information in the areas of: maternal, newborn and child health, family planning and reproductive health. The project is led by PSI and funded by the U.S. Agency for International Development.

With funding from the U.S. Agency for International Development (USAID), RISE is working in select countries, including Ghana, to address the COVID-19 pandemic. In line with ministry of health priorities in each country, RISE’s COVID-19 response support may include: assisting in the planning and rollout of national vaccine plans, including ensuring health care workers are prepared to implement and monitor this plan; providing focused and clinically relevant capacity building for clinicians providing COVID-19 case management; strengthening the oxygen ecosystem; and supporting health care workers in oxygen conservation, rationalization and non-invasive respiratory care.

RISE is a five-year global project—funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and USAID—that works with countries to achieve a shared vision of attaining and maintaining epidemic control, with stronger local partners capable of managing and achieving results through sustainable, self-reliant and resilient health systems. The project is led by Jhpiego with the following partners: ICAP at Columbia University, Management Sciences for Health, Anova, BAO Systems, Johns Hopkins University Center for Public Health and Human Rights, and Mann Global Health. For the COVID-19 ventilator technical assistance effort, RISE is also collaborating with the University of California San Francisco, World Federation of Societies of Anesthesiologists (via the GH STAR project), FHI 360 (via the EpiC Project) and Johns Hopkins University emergency medicine and critical care staff.

With funding from Gavi, the Vaccine Alliance, Jhpiego was identified to support several countries prepare their Equity Accelerator Fund applications through a series of activities aimed to identify and sustainably reach zero dose children and missed communities. The Expanded Programme on Immunization (EPI) in Ghana aims for a 75% reduction in the number of children who have not received the Penta1 vaccine by 2025, through collaborative development and implementation of targeted strategies aimed to reach zero dose children and missed communities. The Jhpiego team in Ghana, with endorsement from EPI,  has coordinated partnership planning and led preparations for the country’s Equity Accelerator Fund application.

Funded by the U.S. Centers for Disease Control and Prevention (CDC), this five-year project builds upon activities funded by CDC to support Global Health Security through implementation of programs and activities that focus on protecting and improving health globally through partnerships with Ministries of Health and other institutions. With an initial emphasis on addressing the COVID-19 pandemic, the project is supporting countries—including Ghana—and carrying out regional work in West Africa and South America to improve prevention of avoidable epidemics, including naturally occurring outbreaks and intentional or accidental releases of dangerous pathogens, and to improve ability to detect threats early and respond rapidly and effectively to public health threats of international concern. The project is being implemented by a Jhpiego-led consortium that includes the Johns Hopkins Center for Health Security, the Johns Hopkins University Applied Physics Laboratory, Global Scientific Solutions for Health, and Johns Hopkins University Center for Global Health.